Development and provision of pharmaceutical products and therapies for various medical conditions.
C
CSR Analysis score
The organization is among the 50% most committed organizations, excluding the top 20%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Octapharma France
B
Development and distribution of therapeutic pharmaceutical products for healthcare professionals and patients.
Baxter
B
Development and provision of medical and technological solutions for healthcare professionals and patients, including primary care, hospital care, surgical care, and kidney care products.
Biocodex
B
Development and provision of pharmaceutical solutions focusing on microbiota care, women's health, and orphan diseases.
Initiatives identified among leaders
Résultats tangibles de la stratégie de décarbonation
“Biocodex a obtenu des résultats tangibles dans sa ...” - BiocodexAssurer un environnement de travail sûr
“Baxter assure un environnement de travail sûr pour...” - BaxterSoutenir les associations de patients
“Octapharma France soutient les associations de pat...” - Octapharma France66% of similar organizations communicate on CSR issues
+4439 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports